Medizin
Refine
Year of publication
- 2020 (394) (remove)
Document Type
- Article (394) (remove)
Has Fulltext
- yes (394)
Keywords
- inflammation (14)
- COVID-19 (11)
- quality of life (7)
- SARS-CoV-2 (6)
- biomarker (6)
- ADHD (5)
- cancer (5)
- depression (5)
- obesity (5)
- ACLF (4)
- Machine learning (4)
- autophagy (4)
- cytokines (4)
- immunotherapy (4)
- macrophage (4)
- pain (4)
- Biomarkers (3)
- Cirrhosis (3)
- HIV (3)
- MRI (3)
- NASH (3)
- acute-on-chronic liver failure (3)
- aortic stenosis (3)
- bipolar disorder (3)
- breast cancer (3)
- child (3)
- chimeric antigen receptor (3)
- complications (3)
- coronavirus (3)
- iron (3)
- macrophages (3)
- microbiome (3)
- neuroblastoma (3)
- outcome (3)
- ovarian cancer (3)
- polytrauma (3)
- portal hypertension (3)
- precision medicine (3)
- prevention (3)
- reactive oxygen species (3)
- schizophrenia (3)
- stroke (3)
- toxicity (3)
- Ascites (2)
- Borrelia (2)
- CD19 (2)
- Cardiovascular magnetic resonance (2)
- Children (2)
- Cohort studies (2)
- EEG (2)
- Europe (2)
- Gene expression (2)
- Germany (2)
- HIV-1 (2)
- Heart failure (2)
- Hepatocellular carcinoma (2)
- Histology (2)
- IL-10 (2)
- Klebsiella pneumoniae (2)
- Language (2)
- Liver diseases (2)
- Liver transplantation (2)
- MSD (2)
- Magnetic resonance imaging (2)
- Multiple sclerosis (2)
- NADPH oxidase (2)
- Neurology (2)
- PCR (2)
- Patients (2)
- Public health (2)
- Quality of life (2)
- Rare diseases (2)
- Register (2)
- Registries (2)
- Registry (2)
- Strength training (2)
- acute lymphoblastic leukemia (2)
- adolescents (2)
- alveolar ridge augmentation (2)
- animal experiment (2)
- antiepileptic drugs (2)
- apoptosis (2)
- attention (2)
- augmentation (2)
- biomarkers (2)
- body mass index (2)
- cardiac surgery (2)
- children (2)
- cirrhosis (2)
- cleaning (2)
- clinical studies (2)
- combination therapy (2)
- complement (2)
- continuous performance test (2)
- cystic fibrosis (2)
- cytomegalovirus (2)
- cytotoxicity (2)
- decompensated liver cirrhosis (2)
- dental education (2)
- dental implants (2)
- dental profession (2)
- diabetes mellitus (2)
- direct-acting antivirals (2)
- elderly (2)
- electroencephalography (2)
- environmental tobacco smoke (2)
- epilepsy (2)
- fibroblasts (2)
- fibrosis (2)
- gait analysis (2)
- glioblastoma (2)
- glioma (2)
- hepatic encephalopathy (2)
- hepatocellular carcinoma (2)
- histology (2)
- hyperactivity (2)
- impulsivity (2)
- integrins (2)
- kidney (2)
- liver (2)
- liver cirrhosis (2)
- lung cancer (2)
- lung function (2)
- machine learning (2)
- mass spectrometry (2)
- mesenchymal stromal cells (2)
- metformin (2)
- microRNA (2)
- migration (2)
- multiple sclerosis (2)
- musculoskeletal disorders (2)
- natural killer cells (2)
- neurodegeneration (2)
- oncology (2)
- pancreatic cancer (2)
- periodontitis (2)
- physical activity (2)
- polygenic risk score (2)
- prevalence (2)
- proliferation (2)
- prostate cancer (2)
- proteome (2)
- proteomics (2)
- risk prediction (2)
- sepsis (2)
- severe acute respiratory syndrome coronavirus 2 (2)
- surgery (2)
- survivin (2)
- tumor growth (2)
- tumor microenvironment (2)
- tumor progression (2)
- von Willebrand factor (2)
- (cardiac) surgery (1)
- 14-3-3 gene family (1)
- 16 segment AHA model (1)
- 16S rRNA sequencing (1)
- 19F MR spectroscopy (1)
- 1H MR spectroscopy (1)
- 2-hydroxyglutarate (1)
- 2019-nCoV (1)
- 3-hydroxyanthranilic acid (1)
- 3D printed cell-free scaffold (1)
- 3D printing (1)
- 3D rapid prototyping (1)
- A-FFIP (1)
- A2BP1 (1)
- ABCB1 (1)
- ABCC1 (1)
- ACE-Bestimmung (1)
- ADAMTS-13 (1)
- ADHD differential diagnosis (1)
- AKI (1)
- AML – acute myeloid leukemia (1)
- ASD-specific (1)
- ATP (1)
- Abdominal aortic aneurysm (1)
- Abdominelles Aortenaneurysma (1)
- Absenteeism (1)
- Access (1)
- Acellular dermis (1)
- Acoustics (1)
- Acute HIV infection (1)
- Acute hospital (1)
- Acute lymphocytic leukaemia (1)
- Addison’s disease (1)
- Adipose tissue (1)
- Advanced breast cancer (1)
- Age determination by skeleton (1)
- Age groups (1)
- Algorithms (1)
- Allergic rhinitis (1)
- Alpha oscillations (1)
- Alzheimer’s disease (1)
- Amino acid analysis (1)
- Andropogon virginicus (1)
- Angiotensin Converting Enzyme (1)
- Angiotensin-converting enzyme (1)
- Anterior cruciate ligament reconstruction (1)
- Anti-CMV IgG (1)
- Anticoagulant therapy (1)
- Anticoagulants (1)
- Antihormone therapy (1)
- Antiviral immune response (1)
- Apoptosis (1)
- Artificial intelligence (1)
- Auditory cortex (1)
- Auditory system (1)
- Autism spectrum disorder (1)
- B cells (1)
- B-cell receptor (1)
- BAG3 (1)
- BCL6 (1)
- BCX7353 (1)
- BDNF (1)
- BFIS (1)
- BG-index (1)
- BIRC5 (1)
- BK channel (1)
- BMI (1)
- BRD4 (1)
- Bathyergidae (1)
- Bee venom allergy (1)
- Benign pulmonary diseases (1)
- Benigne Lungenerkrankungen (1)
- Bestimmungsmethoden (1)
- Bewegungsanalyse mit Inertialsensoren (1)
- Bioavailability prediction (1)
- Biomarker (1)
- Bladder cancer (1)
- Body limbs (1)
- Brain tumors (1)
- Breathing (1)
- C1 inhibitor (1)
- C2 domain (1)
- CAKUT (1)
- CAR (1)
- CD3 (1)
- CD4 binding site (1)
- CD41 (1)
- CD44 (1)
- CD49d (1)
- CD62P (1)
- CD8+ T cell (1)
- CDK9 (1)
- CLP (1)
- CMVepidemiology (1)
- CPT1A (1)
- CRE-dependent transcription (1)
- CUELA system (1)
- CXCL10 (1)
- CXCR3 (1)
- Callous-unemotional traits (1)
- Cancer (1)
- Cancer treatment (1)
- Candida spp (1)
- Cannabidiol (1)
- Cardiac acoustic biomarkers (1)
- Cardiac masses (1)
- CardioMEMS™ HF system (1)
- Cardiology (1)
- Careers (1)
- Cell staining (1)
- Cell-based therapies (1)
- Cellular neuroscience (1)
- Central nervous system (1)
- Cerebrospinal fluid (1)
- Checkpoint inhibitor (1)
- Chemoradiation (1)
- Chemotherapy (1)
- Children and adolescents (1)
- Chromatin accessibility (1)
- Chromatin conformation (1)
- Chronic conditions (1)
- Chronology of disease (1)
- Clinical trials (1)
- Clostridium (1)
- Coagulopathy management (1)
- Cognitive impairment (1)
- Cognitive neurology (1)
- Combo® DTS (1)
- Comparators (1)
- Computed axial tomography (1)
- Computer hardware (1)
- Computer science (1)
- Computer software (1)
- Computer-aided drug design (1)
- Computers (1)
- Concept paper (1)
- Conduct disorder (1)
- Conduct problems (1)
- Congenital CMVinfection (1)
- Congenital anomalies (1)
- Critical Online Reasoning Assessment (1)
- Critical care (1)
- Croatia (1)
- Crohn's disease (1)
- Crohn’s disease (1)
- CspA (1)
- CspZ (1)
- Cyp46a1 (1)
- CysLTR1 (1)
- Cysteine‐Rich Domain (CRD) (1)
- Cytomegalovirus (CMV) (1)
- DAMPs (1)
- DFNB9 (1)
- DILI (1)
- DNA damage (1)
- DNA damage response (1)
- DNA methylation (1)
- DNA sequence analysis (1)
- DNase1-seq (1)
- DTI (1)
- DYRK1A (1)
- Darunavir (1)
- Data processing (1)
- Data protection (1)
- Database searching (1)
- Datenschutz (1)
- Decision making (1)
- Dementia (1)
- Depression (1)
- Dermal fat (1)
- Determination method (1)
- Developmental disorders (1)
- Diabetes mellitus (1)
- Diagnostic markers (1)
- Diagnostics (1)
- Diagnostik (1)
- Disabilities (1)
- Distress screening (1)
- Dravet syndrome (1)
- Drug permeability (1)
- E3 ligase (1)
- EEG reference choices (1)
- EGFR pathway (1)
- EGR1-dependent transcription (1)
- ELISA (1)
- EQIP (1)
- ERBB2 (HER2/neu) (1)
- ES (1)
- ESMO-MCBS (1)
- Early intervention (1)
- Ebola virus (1)
- Echovirus-30 (1)
- Embryos (1)
- Emotions (1)
- End-of-life decisions (1)
- Endovascular repair (1)
- Endovaskuläre Behandlung (1)
- Endpoints (1)
- Epidemiological data (1)
- Epigenetics (1)
- Epilepsy (1)
- Epstein-Barr virus (1)
- Ergonomic analysis (1)
- Ergonomie am Arbeitsplatz (1)
- Ergonomische Analyse (1)
- Ewing sarcoma (1)
- Exercise therapy (1)
- Experts (1)
- External-/self-assessment (1)
- Eye movements (1)
- F508del homozygous (1)
- Factor H (1)
- Fat layer (1)
- Feedback loop (1)
- Fingolimod (1)
- First-line regimen (1)
- Five-Konzept (1)
- Fresh frozen plasma (1)
- Functional clustering (1)
- Functional mitral regurgitation (1)
- G-protein-coupled receptors (1)
- GABA (1)
- GFAP (1)
- GHQ-28 (1)
- GWAS (1)
- Gas gangrene (1)
- Gene expression prediction (1)
- Gene regulation (1)
- General practice (1)
- Gesundheitsamt (1)
- Gαq/11 (1)
- HAE (1)
- HBV filaments (1)
- HBV genotypes (1)
- HBV surface protein (1)
- HCC (1)
- HCC recurrence (1)
- HCV (1)
- HDAC (1)
- HEV (1)
- HFrEF (1)
- HIBCPP cells (1)
- HILI (1)
- HIV-1 escape restriction (1)
- HLA DQ haplotypes (1)
- HNSCC (1)
- Haemodynamic monitoring (1)
- HbA1c (1)
- Health care sector (1)
- Health education and awareness (1)
- Health literacy (1)
- Health policy (1)
- Health services (1)
- Health‐related quality of life (1)
- Heat dissipation (1)
- Hematologic malignancies (1)
- Hematoxylin staining (1)
- Hepatic encephalopathy (1)
- Hepatitis C virus (1)
- Heregulin (1)
- HiC (1)
- HiChIP (1)
- Histoplasma qPCR (1)
- Hmox1 (1)
- Hodgkin lymphoma (1)
- Hodgkin’s lymphoma (1)
- Hospitalization (1)
- House dust mite allergy (1)
- Human behaviour (1)
- Human immunodeficiency virus (HIV) (1)
- Hymenoptera venom immunotherapy (1)
- Hyponatremia (1)
- IDH mutation (1)
- IDH1 inhibitor (1)
- IDO1 (1)
- IFA (1)
- IFN-γ expression (1)
- IKKε (1)
- IL-6 (1)
- IV iron (1)
- IVD degeneration (IVDD) (1)
- IgG (1)
- Image processing (1)
- Image processing (computer-assisted) (1)
- Immune suppression (1)
- Immune system (1)
- Immunohistochemistry (1)
- Immunology (1)
- Immunotherapy (1)
- Implementación (1)
- Implementation (1)
- In vitro (1)
- Induced membrane technique (1)
- Inertial motion capture (1)
- Infections (1)
- Inflammation (1)
- Inflammatory bowel disease (1)
- Intensive care (1)
- Interferons (1)
- Internet (1)
- Intravenous injections (1)
- Ireb2 (1)
- KOOS IV (1)
- Ki-67/MIB1 (1)
- Ki67 transgenic c‐myc/TGFα mice (1)
- Kidney neoplasm (1)
- Kinder (1)
- Kinematic analysis (1)
- Klinische Ergebnisse (1)
- Knees (1)
- Konzeptpapier (1)
- LIR interaction, (1)
- LPS (1)
- Lactobacillus (1)
- Late gadolinium enhancement (1)
- Left hemisphere (1)
- Leukemia (1)
- Lipodystrophy (1)
- Liver transplant (1)
- Local IgE (1)
- Local allergic rhinitis (1)
- Locally advanced (1)
- Loco-regional control (1)
- Long non-coding RNAs (1)
- Low-dose ionizing radiation (1)
- Lower back pain (1)
- Lungenerkrankungen (1)
- Lymph nodes (1)
- Lymphocytes (1)
- Lymphoma (1)
- MAGGIC score (1)
- MCAO (1)
- MICA (1)
- MM-121 (1)
- MMP14 (1)
- MR-spectroscopy (1)
- Machine learning algorithms (1)
- Machine teaching (1)
- Macroautophagy (1)
- Malaria (1)
- Marker genes (1)
- Masquelet technique (1)
- Medical education (1)
- Medical implants (1)
- Medical risk factors (1)
- Meldepflicht (1)
- Membrane potential (1)
- Mesenchymal stromal cells (MSC) (1)
- Mesh (1)
- Metaanalysis (1)
- Metastatic (1)
- MicroRNA-181a (1)
- Microfluidics (1)
- Microglial cells (1)
- Microphysiological models (1)
- Microstates (1)
- Midwifery (1)
- Minimally invasive surgical procedures (1)
- MitraClip (1)
- Mole-rat (1)
- Molecular diagnostic testing (1)
- Morbidity (1)
- Motor control (1)
- Mouse models (1)
- Mucomaix® matrix (1)
- Musculoskeletal diseases (1)
- Muskuloskelettale Erkrankungen (1)
- Mutation databases (1)
- Myocardial perfusion (1)
- Myocardial segmentation (1)
- Myonecrosis (1)
- Mφs (1)
- N2 (1)
- NAFL (1)
- NAFLD (1)
- NDBI (1)
- NF-κB (1)
- NF-кB (1)
- NKG2D (1)
- NPH insulin (1)
- NS1608 (1)
- NSE (1)
- Necrotizing fasciitis (1)
- Neonatal brain damage (1)
- Nephrectomy (1)
- Nesplora Aquarium (1)
- Neural circuits (1)
- Neurodevelopmental disorders (1)
- Neurons (1)
- Neuropathic pain (1)
- Neurophysiology (1)
- Neuropsychological testing (1)
- Neuropsychology (1)
- Neuroscience (1)
- Nivolumab (1)
- Non-allergic-rhinitis (1)
- Non-clear cell renal cell cancer (1)
- Non-small cell lung cancer (1)
- Nordic questionnaire (1)
- Normal distribution (1)
- NoxO1 (1)
- OGTT (1)
- OR time (1)
- Object vision (1)
- Obstetrics (1)
- Offene Versorgung (1)
- Open repair (1)
- Opioids (1)
- Oppositional defant disorder (1)
- Optogenetics (1)
- Organoids (1)
- Oryctolagus cuniculus (1)
- OspE (1)
- Osteonecrosis (1)
- Oxygen (1)
- PARK2 (1)
- PBMC (peripheral blood mononuclear cells) (1)
- PD-1 inhibitor (1)
- PDE inhibition (1)
- PDE‐5‐inhibitor (1)
- PEA-15 (1)
- PKD (1)
- PKD/IC (1)
- PRNT (1)
- PROM (1)
- PRRT2 (1)
- PYGL (1)
- Pain management (1)
- Pain sensation (1)
- Palliative care (1)
- Parkinson's disease (1)
- Pathologists (1)
- Patient blood management (1)
- Patient information materials (1)
- Patient reported outcomes (1)
- Pediatric patients (1)
- Pericardial effusion (1)
- Pericarditis (1)
- Pgrmc1 (1)
- Phase II trial (1)
- Phase rotors (1)
- Physician-assisted suicide (1)
- Physicians (1)
- Pim-1 (1)
- Plasma transfusion (1)
- Plasma usage (1)
- PolySUMOylation (1)
- Polysomnography (1)
- Portal hypertension (1)
- Portal veins (1)
- Posture (1)
- PreS1 deletion (1)
- Preclinical drug development (1)
- Pre‐Ligand Assembly Domain (PLAD) (1)
- Primary breast lymphoma (1)
- Primary care (1)
- Probability density (1)
- Probability distribution (1)
- Professions (1)
- Protease inhibitor therapy (1)
- Protestantism (1)
- Prototypes (1)
- Präanalytik (1)
- Psycho-oncology (1)
- Psychological stress (1)
- QOL (1)
- Qb-Test (1)
- QbTest® (1)
- Quantitative research (1)
- RBC (1)
- RBFOX1 (1)
- RDoC (1)
- RNA therapeutics (1)
- RNAseq analysis (1)
- RNF4 (1)
- RUCAM (1)
- RULA (1)
- Radiation exposure (1)
- Radical cystectomy (1)
- Radiomics (1)
- Radiotherapy (1)
- Randomised trial (1)
- Randomized controlled trials (1)
- Randomized trial (1)
- Rapid diagnostic test (1)
- Real-time phase contrast (1)
- Rectal cancer (1)
- Renal replacement therapy (1)
- Respiration (1)
- Resting-state (1)
- Retrospective studies (1)
- Review (1)
- Right hemisphere (1)
- Risk factors (1)
- Roussel Uclaf Causality Assessment Method (1)
- Roux-en-Y gastric bypass (1)
- Rush protocol (1)
- S100b (1)
- S1P lyase (1)
- S1P1–5 (1)
- S1PR4 (1)
- SARS‐CoV‐2 (1)
- SENP (1)
- SENP6 (1)
- SF-36 (1)
- SKI II (1)
- SLC20A1 (1)
- SMAD (1)
- SPSS (1)
- STAT3 (1)
- SUMO (1)
- SUMO chains (1)
- Sarcoidosis (1)
- Sarcomas (1)
- Sarkoidose (1)
- Seattle heart failure model (1)
- Seltene Erkrankungen (1)
- Semitendinosus tendon autograft (1)
- Senescence (1)
- Sensorimotor processing (1)
- Seribantumab (1)
- Seroconverter (1)
- Seroprevalence (1)
- Single-Molecule Localization Microscopy (SMLM) (1)
- Skin morphology (1)
- Slc11a2 (1)
- Slc25a37 (1)
- Sleep (1)
- Sleep deprivation (1)
- Social information processing (1)
- Social participation (1)
- Soft tissue infection (1)
- Software tools (1)
- Speech (1)
- Sports and exercise medicine (1)
- StUbL (1)
- Statistical data (1)
- Stroke (1)
- Störfaktoren (1)
- Sub-segmentation (1)
- Subterranean (1)
- Sunitinib (1)
- Surgeons (1)
- Surgical and invasive medical procedures (1)
- Surveys (1)
- Syllables (1)
- Symptome (1)
- T-tubule system (1)
- T1 and T2 mapping (1)
- TAPSE (1)
- TAVI (1)
- TBK1 (1)
- TBSS (1)
- TGF-beta (1)
- TGFβ (1)
- THV (1)
- TLR2/6 (1)
- TRPA1 (1)
- TSC22D3 (1)
- TVT (1)
- Tabakkonsum (1)
- Tagging (1)
- Tamponade (1)
- Temsirolimus (1)
- Tendon incontinence repair (1)
- Tendon transplantation (1)
- Tfrc (1)
- Thermoregulation (1)
- Toll-like receptor (1)
- Torque (1)
- Transcatheter Aortic Valve Implantation (1)
- Transcriptome analysis (1)
- Transfusion (1)
- Transitional cell carcinoma (1)
- Transportation (1)
- Treatment modification (1)
- Treatment outcome (1)
- UPPS (1)
- Ulcerative colitis (1)
- Ultra-rush protocol (1)
- Undergraduates (1)
- Urothelial cancer (1)
- VHH (1)
- VIGALL (1)
- VLA4 (1)
- Validation (1)
- Vascularization (1)
- Veins (1)
- Vespid venom allergy (1)
- Viral infection (1)
- Vmem (1)
- Wearable cardioverter‐defibrillator (1)
- Workplace ergonomics (1)
- YM155 (1)
- YWHAE (1)
- YWHAZ (1)
- Yellow fluorescent protein (1)
- abuse (1)
- abuso (1)
- academic medicine (1)
- acetylation (1)
- acetylcholinesterase (1)
- acid dentine lysate (1)
- acquired drug resistance (1)
- actin dynamics (1)
- action sounds (1)
- action-effect association (1)
- activities of daily life (1)
- activity-based benefits (1)
- acute coronary syndromes (1)
- acute decompensation (1)
- acute decompensation of cirrhosis (1)
- acute kidney injury (1)
- acute myeloid leukaemia (1)
- acute respiratory distress syndrome (1)
- acute-on-chronic liver failure (ACLF) (1)
- acute‐on‐chronic liver failure (1)
- adaptation (1)
- adaptive cardiac remodelling (1)
- adaptive immunity (1)
- adenovirus (1)
- adolescentes (1)
- adoptive cancer immunotherapy (1)
- adrenoceptors (1)
- adult and elderly patients (1)
- advanced care planning (1)
- adverse events (1)
- aerobic exercise (1)
- aerodynamics (1)
- affective disorder (1)
- affective disorders (1)
- affinity purification (1)
- aftercare structures (1)
- age (1)
- aggressiveness (1)
- air flow (1)
- alcohol use disorder (1)
- alirocumab (1)
- alkaloid (1)
- allergy (1)
- allocation (1)
- alpharetroviral vector (1)
- alternative oxidase (1)
- amblyopia (1)
- amino acid PET (1)
- amlexanox (1)
- amyloid beta-peptides (1)
- anal cancer (1)
- anemia (1)
- angiography (1)
- animal (1)
- animal model (1)
- annual bleeding rate (1)
- anti-chronic myeloid leukemia (1)
- anti-diabetes (1)
- anti-inflammatory agents (1)
- anti-inflammatory effects (1)
- anti-skin aging (1)
- anti-tumor activity (1)
- antibiotic treatment (1)
- antibody tests (1)
- anticoagulation (1)
- antigen (1)
- antigenic variation (1)
- antigens of infectious origin (1)
- antioxidant defense (1)
- antioxidants (1)
- antireflux surgery (1)
- antiresorptive agents (1)
- antiseizure (1)
- antiviral (1)
- antiviral peptide (1)
- aprotinin (1)
- arousal (1)
- artesunate (ART) (1)
- artificial intelligence (1)
- ascites (1)
- aspirin (1)
- asthma (1)
- asthma phenotypes (1)
- asymptomatic (1)
- ataxia telangiectasia (1)
- athletes (1)
- atopy (1)
- auditory prediction (1)
- autism (1)
- autism spectrum disorder (1)
- autograft (1)
- autoimmune diabetes (1)
- autoimmune polyglandular syndrome type 2 (1)
- autoimmune thyroiditis (1)
- autoreactivity (1)
- bacterial translocation (1)
- balloon pulmonary angioplasty (1)
- basal insulin (1)
- behavioral adverse events (1)
- berotralstat (1)
- biglycan (1)
- biobank (1)
- biological maturation (1)
- biomarker study (1)
- biomechanics (1)
- biopsy naïve (1)
- bladder cancer (BCa) (1)
- bladder exstrophy-epispadias complex (1)
- blood (1)
- blood flow recovery (1)
- blood flow restriction (1)
- blood loss (1)
- blood-brain barrier (1)
- blood-cerebrospinal fluid barrier (1)
- body dysmorphic disorder (1)
- body plethysmography (1)
- bone healing (1)
- bone marrow (1)
- bone marrow mononuclear cells (1)
- bone tissue regeneration (1)
- brain anatomy (1)
- brain function (1)
- brain metastases (1)
- brain-derived neurotrophic factor (1)
- broad-range qPCR (1)
- broadly neutralizing antibodies (1)
- bronchiolitis obliterans syndrome (1)
- buccal mucosal graft urethroplasty (1)
- bundle (1)
- butyrylcholinesterase (1)
- cART (1)
- cBioPortal (1)
- cHL (1)
- calcium handling (1)
- calcium-sensor (1)
- cancer immunobiology (1)
- candidemia (1)
- cannabidiol (1)
- cannabinoids (1)
- cannabis (1)
- capsaicin (1)
- carbapenem resistance (1)
- carbapenemase (1)
- carcinoma (1)
- cardiac (1)
- cardiac I/R injury (1)
- cardiac ischaemia‐reperfusion (1)
- cardiac magnetic (1)
- cardiac rehabilitation (1)
- cardiomyopathy (1)
- career promotion (1)
- cartilage oligomeric matrix protein (1)
- catheter (1)
- cell and focal adhesion (1)
- cell motility (1)
- cell proliferation (1)
- cell survival (1)
- cells (1)
- cellular immunology (1)
- cellular reaction (1)
- cellular therapy (1)
- central nervous system (1)
- cetuximab-bevacizumab therapy sequence (1)
- changes immune activation (1)
- chaperones (1)
- checklist (1)
- chelation therapy (1)
- chemokine receptor 4 (1)
- chemokines (1)
- chemoresistance (1)
- chemotherapeutics-treated (1)
- chest trauma (1)
- children and adolescents (1)
- chloroplasts (1)
- cholestasis (1)
- cholinesterase (1)
- chronic coronary artery disease (1)
- chronic illness (1)
- chronic inflammation (1)
- chronic kidney disease (1)
- chronic liver disease (1)
- chronic metabolic acidosis (1)
- chronic myeloid leukemia (1)
- chronic thromboembolic pulmonary hypertension (1)
- chronic total occlusion (1)
- chronische Niereninsuffizienz (1)
- chronische metabolische Azidose (1)
- circulation (1)
- cisplatin resistance (1)
- cisplatin sensitivity (1)
- clinical (1)
- clinical benefit (1)
- clinical history (1)
- clinical pathways (1)
- clinical study (1)
- clinically important restrictions and symptoms (1)
- cloacal malformation (1)
- clock genes (1)
- clopidogrel (1)
- co-crystallization (1)
- cochlear implant (1)
- coffee (1)
- cognition (1)
- cognitive decline (1)
- collagen type I (1)
- collagen-based matrix (1)
- collateral growth (1)
- colon carcinoma (1)
- common genetic variation (1)
- common variants (1)
- comparative pathology (1)
- complement; patients (1)
- computational biology (1)
- computational neuroimaging (1)
- computed tomography (1)
- computer vision (1)
- computer-assisted (1)
- confidence (1)
- consolidation treatment (1)
- contact heat evoked potentials (CHEPS) (1)
- contralateral delay activity (1)
- coping (1)
- coronary artery bypass surgery (1)
- coronary artery disease (1)
- coronavirus disease 2019 (1)
- cortex, gray matter (1)
- cortical folding (1)
- cortisol (1)
- cost-of-illness (1)
- cranberry (1)
- critical care (1)
- cryogenic electron microscopy (1)
- curcumin (1)
- cyclophosphamide (1)
- cytarabin (1)
- cytokine gene expression (1)
- cytokine-induced killer cells (1)
- dapagliflozin (1)
- data science (1)
- day clinic (1)
- decision making (1)
- decision support systems (1)
- decision-making (1)
- declaration of tobacco ingredients (1)
- decomposition (1)
- decorin (1)
- deep mutational scanning (1)
- deep sedation (1)
- delayed auditory feedback (1)
- delirium (1)
- dendritic cells (1)
- dental assistants (1)
- dental emergency treatment (1)
- dentin adhesives (1)
- dentist (1)
- dentistry (1)
- dentists (1)
- dentoalveolar surgery (1)
- depressive symptoms clusters (1)
- detoxification (1)
- deubiquitinating enzyme (1)
- development (1)
- diabetes (1)
- diabetes therapy (1)
- diagnosis (1)
- diagnostic algorithm (1)
- diagnostic test (1)
- diet (1)
- differentiation (1)
- diffusion tensor imaging (1)
- digital pathology (1)
- dihydroceramide (1)
- disease modelling (1)
- disease models (1)
- dislocation (1)
- distress (1)
- diuretics (1)
- docking studies (1)
- dog study (1)
- drug delivery (1)
- drug discovery (1)
- drug resistance (1)
- drug‐resistant epilepsy (1)
- dual antiplatelet therapy (1)
- dysbiosis (1)
- dysferlin (1)
- dysferlinopathy (1)
- e-Health (1)
- e-scooter (1)
- early myocardial damage (EMD) (1)
- early recognition (1)
- economic burden (1)
- effect mechanism (1)
- effectiveness (1)
- efficacy (1)
- eight disorders (1)
- elderly patients (1)
- electric scooter (1)
- electroencephalography (EEG), EEG reference choices, event-related potentials (ERP), independent component analysis (ICA), pain research, contact heat evoked potentials (CHEPS) (1)
- electrolytic cleaning (1)
- electron transport chain (1)
- elite athlete (1)
- embolization (1)
- emergence (1)
- empagliflozin (1)
- encoding (1)
- end of life care (1)
- endocannabinoids (1)
- endometrial cancer (1)
- endothelial cells (1)
- enterovirus (1)
- epidermal growth factor receptor (1)
- epididymitis (1)
- epigenetic (1)
- epileptic encephalopathy (1)
- epithelial cells (1)
- epithelial‐mesenchymal transition (1)
- epitope mapping (1)
- erectile dysfunction (1)
- ergonomics (1)
- erythropoietin (EPO) (1)
- escape mutations (1)
- ethyl pyruvate (1)
- event logs (1)
- event-related potentials (1)
- event-related potentials (ERP) (1)
- ex vivo model (1)
- ex-Gaussian analysis (1)
- exercise (1)
- exercise on prescription (1)
- experimental human pain models (1)
- expertise (1)
- exposure (1)
- extensively drug-resistant (1)
- external fixation (1)
- external joint moments (1)
- extracellular matrix (1)
- extraction socket healing (1)
- extraversion (1)
- extremity (1)
- eye-tracking (1)
- face inversion effect (1)
- facial nerve functional outcome (1)
- factor VIII (FVIII) (1)
- familial infantile epilepsy (1)
- fasting (1)
- fatigue (1)
- feeder cells (1)
- femoral artery ligation (1)
- fenfluramine (1)
- ferric carboxymaltose (1)
- fibromodulin (1)
- fingolimod (1)
- fixation (1)
- flow cytometry (1)
- focal seizures (1)
- forensic entomology (1)
- formalin-fixed paraffin-embedded (FFPE) samples (1)
- fourth (1)
- fractional anisotropy (1)
- fracture (1)
- free gingival graft (1)
- fully human (1)
- fumonisin B1 (1)
- functional genetics (1)
- functional imaging (1)
- fundoplication (1)
- furcation involvement (1)
- further education (1)
- gap junction protein alpha 4-genotype (1)
- gas chromatography-mass spectrometry (1)
- gastric surgery (1)
- gastroesophageal reflux (1)
- gender (1)
- gender difference (1)
- gene therapy (1)
- genetic diversity (1)
- genetic generalized epilepsy (1)
- genetic phenotypes (1)
- genetic polymorphisms (1)
- genetic predisposition (1)
- genome-wide association study (1)
- germ cell tumors (1)
- glucose metabolism (1)
- glycosaminoglycan (1)
- graft (1)
- grey matter volume (1)
- growth (1)
- growth inhibition (1)
- gyrification (1)
- haematologic malignancies (1)
- haemophilia A (1)
- haemophilic arthropathy (1)
- haemostasis (1)
- harmine (1)
- health care (1)
- health-related quality of life (1)
- healthcare workers (1)
- healthy subjects (1)
- hearing nerve (1)
- heat stress (1)
- hemadsorption (1)
- hematoma (1)
- hematopoietic stem and progenitor cells (1)
- hemiplegic migraine (1)
- hemispherotomy (1)
- hemodynamic (1)
- hemodynamic instability (1)
- hemophilia A (1)
- hemorrhagic transformation (1)
- hepatic fibrosis (1)
- hepatitis C virus (1)
- hepatitis E (1)
- herb induced liver injury (1)
- hereditary angioedema (1)
- herpes simplex virus (1)
- hiPSC (1)
- high surgical risk (1)
- high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry (1)
- high-throughput nucleotide sequencing (1)
- higher education (1)
- high‐mobility group box‐1 (HMGB1) (1)
- hip joint (1)
- hippocampus (1)
- histological technic (1)
- histomorphometry (1)
- histoplasmosis (1)
- hospitalization (1)
- host-pathogen interaction (1)
- huCAR19 (1)
- human decellularized dermis (1)
- human lymph node (1)
- human sera (1)
- humanized mice (1)
- humanized mouse model (1)
- hyperarousal (1)
- hyperglycemia (1)
- hyperhomocysteinemia (1)
- hypertension (1)
- hypoglycaemia (1)
- hypophosphataemia (1)
- hypoxia (1)
- iDILI (1)
- iDrug induced liver injury (1)
- image-based risk modelling (1)
- immune checkpoint inhibitors (1)
- immune evasion (1)
- immunity (1)
- immunoprecipitation (1)
- immunosuppression (1)
- improvement in quality of life (1)
- in vitro (1)
- in vivo model of critical size defects (1)
- independent component analysis (ICA) (1)
- indoor air pollution (1)
- induced membrane (1)
- induction chemotherapy (1)
- inertial motion capture (1)
- infant (1)
- infants (1)
- infection (1)
- infectious diseases (1)
- inflammatory bowel disease (1)
- inflammatory cytokines (1)
- inflammatory markers (1)
- inhibitors (1)
- injury (1)
- innate and adaptive immune response (1)
- innate immunity (1)
- inner ear therapy (1)
- insomnia (1)
- instructional interventions (1)
- insulin resistance (1)
- insulitis (1)
- integrin (1)
- interactome (1)
- interleukin-6 (1)
- interleukins (1)
- intervertebral disc (IVD) (1)
- intrinsic drug resistance (1)
- invasion (1)
- invasive mold infection (1)
- inverse dynamics (1)
- iron overload versus deprivation (1)
- iron supplements (1)
- irradiation (1)
- ischaemia (1)
- joint bleeding (1)
- joint contact forces (1)
- joint loading (1)
- joint moments (1)
- juvenile brain lesion (1)
- kallikrein inhibitor (1)
- keratinized mucosa (1)
- ketogenic (1)
- ketone body (1)
- kidney formation (1)
- kidney function (1)
- kinematics (1)
- kinetic fingerprint (1)
- knee joint (1)
- kynureninase (1)
- kynurenine (1)
- lacosamide (1)
- lamotrigine (1)
- latent class analysis (1)
- left ventricular non-compaction (1)
- left ventricular trabeculation (1)
- leg alignment (1)
- lentiviral vector (1)
- leukocytes (1)
- leukopenia (1)
- levetiracetam (1)
- light microscopy (1)
- limb girdle muscular dystrophy type 2B (LGMD2B) (1)
- lipid raft (1)
- lipidomic analysis (1)
- lipocalin-2 (1)
- liquid PRF (1)
- liver transplantation (1)
- liver transplantation center (1)
- local inflammation (1)
- long reads (1)
- long-term outcome (1)
- long-term prophylaxis (1)
- long-term survival (1)
- longevity (1)
- longitudinal follow-up after epilepsy surgery (1)
- loss (1)
- low doses (1)
- low-density lipoprotein cholesterol (1)
- low-risk (1)
- lower extremity arterial disease (1)
- lumican (1)
- lung disease phenotype (1)
- lymphocytes (1)
- lymphoma (1)
- mRNA and protein expression (1)
- macrophage polarization (1)
- magentoencephalography (MEG) (1)
- magnetic resonance imaging of the brain (1)
- maintenance (1)
- major adverse cardiovascular events (1)
- major depression (MD) (1)
- major depressive disorder (MDD) (1)
- mammary carcinomas (1)
- management (1)
- mandatory reporting (1)
- maternal tobacco smoke (1)
- mathematical modeling (1)
- matrikine (1)
- matrix metalloproteinases (1)
- mean diffusivity (1)
- mechanism of action (1)
- melanoma (1)
- membrane potential (1)
- membrane repair (1)
- memory and learning tests (1)
- mesenchymal stem cell (1)
- metabolic reprogramming (1)
- metabolic syndrome (1)
- mice (1)
- micro CT (1)
- microlesions (1)
- microsurgical treatment (1)
- migration and invasion (1)
- mini gastric bypass (1)
- minimal clinically important difference (1)
- mir-148a (1)
- mitochondria (1)
- mitochondrial dysfunction (1)
- model psychosis (1)
- molecular tumor board (1)
- molecular typing (1)
- monoamine oxidase A (1)
- monocyte chemotactic protein 1 (MCP-1) (1)
- mononuclear cell (1)
- morphogenesis (1)
- morphological filtering (1)
- morphometry (1)
- mortality (1)
- motion analysis (1)
- mouse (1)
- mouse model (1)
- mouse models (1)
- movement pattern (1)
- movement profile (1)
- multimodal complex treatment (1)
- multimorbidity (1)
- multiple trauma (1)
- murine model (1)
- muscle (1)
- muscle disease (1)
- muscular dystrophy (1)
- musculoskeletal (1)
- musculoskeletal modeling (1)
- musculoskeletal pain (1)
- mutational antigenic profiling (1)
- myocardial perfusion (1)
- myoferlin (1)
- myotonia congenita (1)
- nanobodies (1)
- narrative content analysis (1)
- narrative economics (1)
- narrative medicine (1)
- natriuretic peptide (1)
- natural cytotoxicity (1)
- natural killer cell (1)
- naturalistic sample (1)
- necrosis (1)
- neglect (1)
- negligencia (1)
- neonate (1)
- neonates (1)
- neonatology (1)
- neoplasms (1)
- networks (1)
- neural oscillations (1)
- neurogenesis (1)
- neurological impairment (1)
- neuronal maturation (1)
- neuropathy (1)
- neurophysiology (1)
- neuropsychology (1)
- neuroticism (1)
- neurovascular bundle preservation (1)
- neutralization (1)
- neutralizing antibodies (1)
- newborn (1)
- newborn screening (1)
- niños (1)
- non-malignant hematological diseases (1)
- noninterventional (1)
- non‐selective beta‐blocker (1)
- nucleotide analogue (1)
- nucleotide metabolism (1)
- observational study (1)
- occupational health (1)
- off-pump surgery (1)
- oncological gastrectomy (1)
- oncological outcome (1)
- one anastomosis gastric bypass (1)
- online information processing (1)
- online reasoning patterns (1)
- online survey (1)
- operative (1)
- optical coherence tomography (1)
- oral and maxillofacial surgery (1)
- orientation (1)
- osteogenic sarcoma cells (1)
- osteoimmunological changes (1)
- otoferlin (1)
- ouabain (1)
- outcomes (1)
- ovary (1)
- overweight (1)
- own-face perception (1)
- oxidised lipids (1)
- pacemaker implantation (1)
- pain questionnaire (1)
- pain research (1)
- pancreatic surgery (1)
- parkinson’s disease (1)
- passive immunization (1)
- passive smoke (1)
- patient centered care (1)
- patient preferences (1)
- patient questionnaire (1)
- patient triage (1)
- patient-reported outcome measure (1)
- patient’s perspective (1)
- paxilline (1)
- peanut allergy (1)
- pediatric (1)
- pediatric epilepsy (1)
- pediatric eye screening (1)
- pediatrics (1)
- pelvic packing (1)
- pelvic ring fracture (1)
- performance assessment (1)
- peri-implantitis (1)
- periimplantitis (1)
- perineurium (1)
- periodontal disease progression (1)
- periodontal risk assessment (1)
- periodontal risk calculator (1)
- perioperative outcome (1)
- perioperative period (1)
- peripheral arterial disease (1)
- peri‐implantitis (1)
- peri‐implantitis therapy (1)
- person-oriented approach (1)
- personalised therapy (1)
- pet rabbit (1)
- phage (1)
- phage display (1)
- phage therapy (1)
- pharmacoresistance (1)
- phenotype/genotype relation (1)
- phenotypic spectrum (1)
- phosphate (1)
- phosphorus (1)
- physical activity counseling (1)
- pigs (1)
- plasma-derived factor VIII concentrate, prophylaxis (1)
- plasmid (1)
- plasticity (1)
- polo-like kinase 1 (1)
- polylactide (1)
- polyomavirus (1)
- polysomnography (1)
- population dynamics (1)
- portosystemic shunt (1)
- post-liver transplantation management (1)
- post-traumatic (1)
- postmortem interval (1)
- postoperative complications (1)
- postoperative delirium (1)
- posttransnational modification (1)
- posttraumatic inflammation (1)
- posttraumatic stress disorder (1)
- ppi1 (1)
- pre-school asthma (1)
- prediabetes (1)
- preschool health examination (1)
- preventive medicine (1)
- primary biliary cirrhosis (1)
- primary sclerosing cholangitis (1)
- proanthocyanidin (1)
- process mining (1)
- prognosis (1)
- prognostic value (1)
- proinflammatory microenvironment (1)
- promotion index (1)
- prophylactic vaccine (1)
- prophylaxis (1)
- proprotein convertase subtilisin/kexin type 9 inhibition (1)
- prostate volume (1)
- protein quality control (1)
- proteoglycan (1)
- proteostasis (1)
- proximal tubule (1)
- psoriasis (1)
- psycho-oncology (1)
- psychosocial adjustment (1)
- public health department (1)
- public mental health (1)
- qRT-PCR detection (1)
- quality (1)
- quality of care (1)
- quantitative proteomics (1)
- quantitative sensory testing (1)
- questionnaire (1)
- radiation oncology (1)
- radioimmunotherapy (1)
- radiomic (1)
- radiotherapy (1)
- radon therapy (1)
- rare disease (1)
- rare diseases (1)
- rare variants (1)
- rct (1)
- re-osseointegration (1)
- re-transplantation (1)
- readmission rates (1)
- receptor for advanced glycation end product (RAGE) (1)
- recombinant vesicular stomatitis virus‐Zaire ebolavirus (1)
- regulatory T cells (1)
- relapsing fever (1)
- reliable change index (1)
- remodelling (1)
- renal cell cancer (1)
- renal cell carcinoma (1)
- renal tubular cells (1)
- renal tubular epithelial cells (1)
- repeat biopsy (1)
- repeated (1)
- reperfusion injury (1)
- repetition suppression (RS) (1)
- repetitive firing (1)
- repsonse process patterns (1)
- requirements analysis (1)
- resective surgery (1)
- resistance (1)
- resolution (1)
- resonance (1)
- resting EEG (1)
- rhabdomyosarcoma (1)
- rheumatoid arthritis (1)
- ridge preservation (1)
- right heart catheter (1)
- risk factors (1)
- risk score (1)
- sCD163 (1)
- sCD206 (1)
- safety (1)
- sarcoma (1)
- sarcopenia (1)
- scavenger receptor (1)
- sciatic nerve (1)
- screening (1)
- second-hand smoke (1)
- seizures (1)
- selective autophagy receptor (1)
- self‐expanding (1)
- sensory neuropathy (1)
- serology (1)
- severe acute respiratory syndrome coronavirus (1)
- severe asthma (1)
- severe congenital neutropenia (1)
- sex (1)
- shock filter (1)
- short linear motifs (SLiMs) (1)
- shrinkage (1)
- shunt (1)
- sialitis (1)
- sickle cell anemia (1)
- simulation training (1)
- sleepiness (1)
- small molecule inhibitor (1)
- smoking in pregnancy (1)
- social determinants (1)
- social isolation (1)
- socioeconomic status (1)
- soft drinks (1)
- soluble MICA (1)
- sphingosine 1-phoshate (1)
- sphingosine 1-phosphate antagonistst/inhibitors (1)
- sphingosine 1-phosphate metabolism (1)
- sphingosine 1-phosphate receptor (1)
- sphingosine 1-phosphate signaling (1)
- sphingosine kinase (1)
- sphingosine-1-phosphate (1)
- spiral ganglion cells (1)
- spirochetes (1)
- spirometry (1)
- spontaneous portosystemic shunt (1)
- sport (1)
- sports (1)
- standardization (1)
- standardized regression-based change norms (1)
- steroid control of aging (1)
- stiripentol (1)
- stress (1)
- stress response (1)
- stretching (1)
- stromal-derived factor 1 (1)
- structure–activity relationships (1)
- substance abuse disorder (1)
- suicidality (1)
- suicide (1)
- sulforaphane (1)
- supervision (1)
- supervisión (1)
- supplementary motor area (1)
- suprapubic catheter (1)
- surgical margin (1)
- surgical procedures (1)
- survival (1)
- sympathicus (1)
- symptoms (1)
- synergistic interaction (1)
- synovium (1)
- synuclein (1)
- systematic biopsy (1)
- tailored treatment schedule (1)
- talent development (1)
- talent identification (1)
- targeted biopsy (1)
- targeted therapy (1)
- targeting (1)
- tea (1)
- telemedicine (1)
- terapia cognitivo conductual enfocada en trauma (1)
- test protocol (1)
- testis (1)
- tetrahydrocannabinol (1)
- thalassemia (1)
- therapy monitoring (1)
- therapy resistance (1)
- thiazolidine and perhydrothiazine derivatives of aldophosphamide and I-aldophosphamide (1)
- third (1)
- three-dimensional analysis (1)
- three‐dimensional analysis (1)
- thrombopenia (1)
- thrombosis (1)
- thrombotic microangiopathy (1)
- thrombotic thrombocytopenic purpura (1)
- tick (1)
- time-lapse imaging (1)
- tissue slice co-cultures (1)
- tobacco control (1)
- tobacco products (1)
- toc64 (1)
- tooth (1)
- tooth autotransplantation (1)
- tooth transplantation (1)
- total body score (1)
- traffic accident (1)
- training effects (1)
- transcatheter aortic valve replacement (TAVR) (1)
- transcatheter aortic valve replacement (TAVR), aortic valve stenosis (AS) (1)
- transcriptome (1)
- transcriptomics (1)
- transforming growth factor-β (1)
- transfusion (1)
- transgenically augmented CAR NK cell (1)
- transjugular intrahepatic portosystemic shunt (TIPS) (1)
- transjugular portosystemic intrahepatic (1)
- translational medical research (1)
- translational medicine (1)
- translational reseach (1)
- translocon (1)
- transmission routes (1)
- transplantation (1)
- transportation (1)
- transrectal prostate biopsy (1)
- transurethral catheter (1)
- transverse axis (1)
- trauma (1)
- traumafocused cognitive behavioural therapy (1)
- traumatic brain injury (1)
- traumatic brain injury (TBI) (1)
- treatment-related changes (1)
- trigeminal pain (1)
- trophoblast (1)
- tryptophan (1)
- tumor adhesion (1)
- tumor infiltrating lymphocytes (1)
- tumor invasion (1)
- tumor migration (1)
- tumor pain (1)
- tumor stroma (1)
- tumor xenograft (1)
- tumor-associated macrophages (1)
- type 1 diabetes (1)
- type-1-diabetes (1)
- tyrosinase inhibitor (1)
- tyrosine kinase inhibitors. (1)
- ubiquitin (1)
- ubiquitin receptor (1)
- unanticipated (1)
- unilateral hip osteoarthritis (1)
- urethral stricture (1)
- urethroplasty (1)
- urinary tract development (1)
- vaccination (1)
- vacuuming (1)
- valproic acid (1)
- value frameworks (1)
- variability (1)
- vascular endothelial growth factor receptor (1)
- vascular surgery (1)
- vector (1)
- venturesomeness (1)
- vestibular schwannoma (1)
- vigilance (1)
- vincristine (1)
- viral infection (1)
- visual priming (1)
- vitamin B deficiency (1)
- vitamin D (1)
- vitamin D deficiency (1)
- vitamin D metabolites (1)
- volatile sedation (1)
- von Willebrand diseases (1)
- weight loss (1)
- wheezing (1)
- whole abdominal radiotherapy (1)
- whole genome sequencing (1)
- whole slide image (1)
- wild boar carcass (1)
- working memory (1)
- workplace health promotion (1)
- youth football (1)
- zebrafish development (1)
- Übertragungswege (1)
- α-amylase inhibitor (1)
- α-particles (1)
- γ‐H2AX (1)
Institute
- Medizin (394) (remove)
The incidence of FIX inhibitors in severe hemophilia B (SHB) is not well defined. Frequencies of 3-5% have been reported but most studies to date were small, including patients with different severities, and without prospective follow-up for inhibitor incidence. Study objective was to investigate inhibitor incidence in patients with SHB followed up to 500 exposure days (ED), the frequency of allergic reactions, and the relationship with genotypes. Consecutive previously untreated patients (PUPs) with SHB enrolled into the PedNet cohort were included. Detailed data was collected for the first 50 ED, followed by annual collection of inhibitor status and allergic reactions. Presence of inhibitors was defined by at least two consecutive positive samples. Additionally, data on factor IX gene mutation was collected. 154 PUPs with SHB were included; 75% were followed until 75 ED, and 43% until 500 ED. Inhibitors developed in 14 patients (7 high-titre). Median number of ED at inhibitor manifestation was 11 (IQR 6.5-36.5). Cumulative inhibitor incidence was 9.3% (95%CI 4.4-14.1) at 75 ED, and 10.2% (5.1-15.3) at 500 ED. Allergic reactions occurred in 4 (28.6%) inhibitor patients. Missense mutations were most frequent (46.8%) overall but not associated with inhibitors. Nonsense mutations and deletions with large structural changes comprised all mutations among inhibitor patients and were associated with an inhibitor risk of 26.9% and 33.3%, respectively. In an unselected, well-defined cohort of PUPs with SHB, cumulative inhibitor incidence was 10.2% at 500 ED. Nonsense mutations and large deletions were strongly associated with the risk of inhibitor development. The PedNet Registry is registered at clinicaltrials.gov; identifier: NCT02979119
Introduction: In recent years, resource-saving handling of allogeneic blood products and a reduction of transfusion rates in adults has been observed. However, comparable published national data for transfusion practices in pediatric patients are currently not available. In this study, the transfusion rates for children and adolescents were analyzed based on data from the Federal Statistical Office of Germany during the past 2 decades. Methods: Data were queried via the database of the Federal Statistical Office (Destasis). The period covered was from 2005 to 2018, and those in the sample group were children and adolescents aged 0–17 years receiving inpatient care. Operation and procedure codes (OPS) for transfusions, procedures, or interventions with increased transfusion risk were queried and evaluated in detail. Results: In Germany, 0.9% of the children and adolescents treated in hospital received a transfusion in 2018. A reduction in transfusion rates from 1.02% (2005) to 0.9% (2018) was observed for the total collective of children and adolescents receiving inpatient care. Increases in transfusion rates were recorded for 1- to 4- (1.41–1.45%) and 5- to 10-year-olds (1.24–1.33%). Children under 1 year of age were most frequently transfused (in 2018, 40.2% of the children were cared for in hospital). Transfusion-associated procedures such as chemotherapy or machine ventilation and respiratory support for newborns and infants are on the rise. Conclusion: Transfusion rates are declining in children and adolescents, but the reasons for increases in transfusion rates in other groups are unclear. Prospective studies to evaluate transfusion rates and triggers in children are urgently needed.
Background: Plasma transfusions are most commonly used therapeutically for bleeding or prophylactically in non-bleeding patients prior to invasive procedures or surgery. Although plasma transfusions generally seem to decline, plasma usage for indications that lack evidence of efficacy prevail. Summary: There is wide international, interinstitutional, and interindividual variance regarding the compliance with guidelines based on published references, supported by appropriate testing. There is furthermore a profound lack of evidence from randomized controlled trials comparing the effect of plasma transfusion with that of other therapeutic interventions for most indications, including massive bleeding. The expected benefit of a plasma transfusion needs to be balanced carefully against the associated risk of adverse events. In light of the heterogeneous nature of bleeding conditions and their rapid evolvement over time, fibrinogen and factor concentrate therapy, directed at specific phases of coagulation identified by alternative laboratory assays, may offer advantages over conventional blood product ratio-driven resuscitation. However, their outcome benefit has not been demonstrated in well-powered prospective trials. This systematic review will detail the current evidence base for plasma transfusion in adult surgical patients.
Management of decompensated cirrhosis is currently geared towards the treatment of complications once they occur. To date there is no established disease-modifying therapy aimed at halting progression of the disease and preventing the development of complications in patients with decompensated cirrhosis. The design of clinical trials to investigate new therapies for patients with decompensated cirrhosis is complex. The population of patients with decompensated cirrhosis is heterogeneous (i.e., different etiologies, comorbidities and disease severity), leading to the inclusion of diverse populations in clinical trials. In addition, primary endpoints selected for trials that include patients with decompensated cirrhosis are not homogeneous and at times may not be appropriate. This leads to difficulties in comparing results obtained from different trials. Against this background, the LiverHope Consortium organized a meeting of experts, the goal of which was to develop recommendations for the design of clinical trials and to define appropriate endpoints, both for trials aimed at modifying the natural history and preventing progression of decompensated cirrhosis, as well as for trials aimed at managing the individual complications of cirrhosis.
Objectives: An increasing number of treatment-determining biomarkers has been identified in non-small cell lung cancer (NSCLC) and molecular testing is recommended to enable optimal individualized treatment. However, data on implementation of these recommendations in the “real-world” setting are scarce. This study presents comprehensive details on the frequency, methodology and results of biomarker testing of advanced NSCLC in Germany.
Patients and methods: This analysis included 3,717 patients with advanced NSCLC (2,921 non-squamous; 796 squamous), recruited into the CRISP registry at start of systemic therapy by 150 German sites between December 2015 and June 2019. Evaluated were the molecular biomarkers EGFR, ALK, ROS1, BRAF, KRAS, MET, TP53, RET, HER2, as well as expression of PD-L1.
Results: In total, 90.5 % of the patients were tested for biomarkers. Testing rates were 92.2 % (non-squamous), 70.7 % (squamous) and increased from 83.2 % in 2015/16 to 94.2% in 2019. Overall testing rates for EGFR, ALK, ROS1, and BRAF were 72.5 %, 74.5 %, 66.1 %, and 53.0 %, respectively (non-squamous). Testing rates for PD-L1 expression were 64.5 % (non-squamous), and 58.5 % (squamous). The most common testing methods were immunohistochemistry (68.5 % non-squamous, 58.3 % squamous), and next-generation sequencing (38.7 % non-squamous, 14.4 % squamous). Reasons for not testing were insufficient tumor material or lack of guideline recommendations (squamous). No alteration was found in 37.8 % (non-squamous), and 57.9 % (squamous), respectively. Most common alterations in non-squamous tumors (all patients/all patients tested for the respective biomarker): KRAS (17.3 %/39.2 %), TP53 (14.1 %/51.4 %), and EGFR (11.0 %/15.1 %); in squamous tumors: TP53 (7.0 %/69.1 %), MET (1.5 %/11.1 %), and EGFR (1.1 %/4.4 %). Median PFS (non-squamous) was 8.7 months (95 % CI 7.4–10.4) with druggable EGFR mutation, and 8.0 months (95 % CI 3.9–9.2) with druggable ALK alterations.
Conclusion: Testing rates in Germany are high nationwide and acceptable in international comparison, but still leave out a significant portion of patients, who could potentially benefit. Thus, specific measures are needed to increase implementation.
Human lymph nodes play a central part of immune defense against infection agents and tumor cells. Lymphoid follicles are compartments of the lymph node which are spherical, mainly filled with B cells. B cells are cellular components of the adaptive immune systems. In the course of a specific immune response, lymphoid follicles pass different morphological differentiation stages. The morphology and the spatial distribution of lymphoid follicles can be sometimes associated to a particular causative agent and development stage of a disease. We report our new approach for the automatic detection of follicular regions in histological whole slide images of tissue sections immuno-stained with actin. The method is divided in two phases: (1) shock filter-based detection of transition points and (2) segmentation of follicular regions. Follicular regions in 10 whole slide images were manually annotated by visual inspection, and sample surveys were conducted by an expert pathologist. The results of our method were validated by comparing with the manual annotation. On average, we could achieve a Zijbendos similarity index of 0.71, with a standard deviation of 0.07.
Mental imagery provides an essential simulation tool for remembering the past and planning the future, with its strength affecting both cognition and mental health. Research suggests that neural activity spanning prefrontal, parietal, temporal, and visual areas supports the generation of mental images. Exactly how this network controls the strength of visual imagery remains unknown. Here, brain imaging and transcranial magnetic phosphene data show that lower resting activity and excitability levels in early visual cortex (V1-V3) predict stronger sensory imagery. Further, electrically decreasing visual cortex excitability using tDCS increases imagery strength, demonstrating a causative role of visual cortex excitability in controlling visual imagery. Together, these data suggest a neurophysiological mechanism of cortical excitability involved in controlling the strength of mental images.
Background: Berotralstat (BCX7353) is an oral, once-daily inhibitor of plasma kallikrein in development for the prophylaxis of hereditary angioedema (HAE) attacks.
Objective: Our aim was to determine the efficacy, safety, and tolerability of berotralstat in patients with HAE over a 24-week treatment period (the phase 3 APeX-2 trial).
Methods: APeX-2 was a double-blind, parallel-group study that randomized patients at 40 sites in 11 countries 1:1:1 to receive once-daily berotralstat in a dose of 110 mg or 150 mg or placebo (Clinicaltrials.gov identifier NCT03485911). Patients aged 12 years or older with HAE due to C1 inhibitor deficiency and at least 2 investigator-confirmed HAE attacks in the first 56 days of a prospective run-in period were eligible. The primary efficacy end point was the rate of investigator-confirmed HAE attacks during the 24-week treatment period.
Results: A total of 121 patients were randomized; 120 of them received at least 1 dose of the study drug (n = 41, 40, and 39 in the 110-mg dose of berotralstat, 150-mg of dose berotralstat, and placebo groups, respectively). Berotralstat demonstrated a significant reduction in attack rate at both 110 mg (1.65 attacks per month; P = .024) and 150 mg (1.31 attacks per month; P < .001) relative to placebo (2.35 attacks per month). The most frequent treatment-emergent adverse events that occurred more with berotralstat than with placebo were abdominal pain, vomiting, diarrhea, and back pain. No drug-related serious treatment-emergent adverse events occurred.
Conclusion: Both the 110-mg and 150-mg doses of berotralstat reduced HAE attack rates compared with placebo and were safe and generally well tolerated. The most favorable benefit-to-risk profile was observed at a dose of 150 mg per day.
The in vivo firing patterns of ventral midbrain dopamine neurons are controlled by afferent and intrinsic activity to generate sensory cue and prediction error signals that are essential for reward-based learning. Given the absence of in vivo intracellular recordings during the last three decades, the subthreshold membrane potential events that cause changes in dopamine neuron firing patterns remain unknown. To address this, we established in vivo whole-cell recordings and obtained over 100 spontaneously active, immunocytochemically-defined midbrain dopamine neurons in isoflurane-anaesthetized adult mice. We identified a repertoire of subthreshold membrane potential signatures associated with distinct in vivo firing patterns. Dopamine neuron activity in vivo deviated from single-spike pacemaking by phasic increases in firing rate via two qualitatively distinct biophysical mechanisms: 1) a prolonged hyperpolarization preceding rebound bursts, accompanied by a hyperpolarizing shift in action potential threshold; and 2) a transient depolarization leading to high-frequency plateau bursts, associated with a depolarizing shift in action potential threshold. Our findings define a mechanistic framework for the biophysical implementation of dopamine neuron firing patterns in the intact brain.